Image-Guided Hypofractionated Proton Therapy in Early-Stage Non–Small Cell Lung Cancer: A Phase 2 Study

by Shivam M. Kharod, MD, R.Charles Nichols, MD, Randal H. Henderson, MD, MBA, Christopher G. Morris, MS, Dat C. Pham, MD, Vandana K. Seeram, MBBS, Lisa M. Jones, MD, Maria Antonio-Miranda, MD, Daniel A. Siragusa, MD, Zuofeng Li, DSc, Stella Flampouri, PhD, MSc, Bradford S. Hoppe, MD, MPH
Published 2020-11-01

Postoperative or Salvage Proton Radiotherapy for Prostate Cancer After Radical Prostatectomy

by Shivam M. Kharod, MD, Catherine E. Mercado, MD, Christopher G. Morris, MS, Curtis M. Bryant, MD, MPH, Nancy P. Mendenhall, MD, William M. Mendenhall, MD, R. Charles Nichols, MD, Bradford S. Hoppe, MD, MPH, Xiaoying Liang, PhD, Zhong Su, PhD, Zuofeng Li, DSc, Randal H. Henderson, MD, MBA
Published 2021-03-01

Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408

by R. Charles Nichols, MD, Chen Hu, PhD, Jean-Paul Bahary, MD, Kenneth L. Zeitzer, MD, Luis Souhami, MD, Mark H. Leibenhaut, MD, Marvin Rotman, MD, Elizabeth M. Gore, MD, Alexander G. Balogh, MD, David McGowan, MD, Jeff Michalski, MD, Adam Raben, MD, Shari Rudoler, MD, Christopher U. Jones, MD, Howard Sandler, MD
Published 2017-10-01

Consensus Statement on Proton Therapy for Prostate Cancer

by Curtis M. Bryant, MD, MPH, Randal H. Henderson, MD, MBA, R. Charles Nichols, MD, William M. Mendenhall, MD, Bradford S. Hoppe, MD, MPH, Carlos E. Vargas, MD, Thomas B. Daniels, MD, C. Richard Choo, MD, Rahul R. Parikh, MD, Huan Giap, MD, PhD, Jerry D. Slater, MD, Neha Vapiwala, MD, William Barrett, MD, Akash Nanda, MD, PhD, Mark V. Mishra, MD, Seungtaek Choi, MD, Jay J. Liao, MD, Nancy P. Mendenhall, MD, the Genitourinary Subcommittee of the Particle Therapy Co-Operative Group
Published 2021-04-01